Traduction de «évaluation des technologies de santé » (Français → Anglais) :

health technology assessment | HTA

health technology assessment [ HTA | technology assessment ]

Canadian Agency for Drugs and Technologies in Health [ CADTH | Canadian Coordinating Office for Health Technology Assessment ]

World Health Organization (WHO) FRAX 10 year hip fracture probability score

International Assessment of Agricultural Science and Technology for Development (1) | International Assessment of Agricultural Knowledge, Science and Technology for Development (2) [ IAASTD ]

Canadian Coordinating Office for Health Technology Assessment - Pharmaceutical Assessment Program

environmental health impact assessment

Assess health promotion

Assess home health aide service

With the largest internal market in the world it is home to many of the world's leading innovative companies, and has a leading position in many fields of knowledge and key technologies such as health, food, renewable energies, environmental technologies and transport.[1]

Joint clinical assessments focusing on the most innovative and potentially impactful health technologies for maximum EU-added value; Joint scientific consultations whereby developers of a health technology can seek the advice of HTA authorities on what type of data and evidence is likely to be required in the submission for HTA; Identification of emerging health technologies to help ensure that the most promising health technologies for patients and health systems are identified early and included in the joint work; and Voluntary cooperation in areas outside the scope of mandatory cooperation, for example on health technologies oth ...[+++]er than medicines and medical devices (e.g. surgical procedures), or on economic aspects of health technologies.

Member States will be able to use common HTA tools, methodologies and procedures across the EU, working together in four main areas: 1) on joint clinical assessments focusing on the most innovative health technologies with the most potential impact for patients; 2) on joint scientific consultations whereby developers can seek advice from HTA authorities; 3) on identification of emerging health technologies to identify promising technologies early; and 4) on continuing voluntary cooperation in other areas.

4. Considers that providing the tools necessary for harnessing public, real-time data will facilitate a better understanding of benefit-risk, the prediction of adverse events and improvements in the efficiency of health technology assessments;